全文获取类型
收费全文 | 712篇 |
免费 | 49篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 20篇 |
妇产科学 | 24篇 |
基础医学 | 98篇 |
口腔科学 | 28篇 |
临床医学 | 73篇 |
内科学 | 126篇 |
皮肤病学 | 1篇 |
神经病学 | 112篇 |
特种医学 | 33篇 |
外科学 | 27篇 |
综合类 | 2篇 |
预防医学 | 37篇 |
眼科学 | 2篇 |
药学 | 93篇 |
中国医学 | 3篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 1篇 |
2022年 | 4篇 |
2021年 | 8篇 |
2020年 | 12篇 |
2019年 | 18篇 |
2018年 | 14篇 |
2017年 | 13篇 |
2016年 | 9篇 |
2015年 | 21篇 |
2014年 | 18篇 |
2013年 | 40篇 |
2012年 | 43篇 |
2011年 | 40篇 |
2010年 | 24篇 |
2009年 | 27篇 |
2008年 | 48篇 |
2007年 | 44篇 |
2006年 | 40篇 |
2005年 | 35篇 |
2004年 | 39篇 |
2003年 | 53篇 |
2002年 | 24篇 |
2001年 | 18篇 |
2000年 | 10篇 |
1999年 | 16篇 |
1998年 | 13篇 |
1997年 | 12篇 |
1996年 | 13篇 |
1995年 | 8篇 |
1994年 | 8篇 |
1993年 | 7篇 |
1992年 | 9篇 |
1991年 | 9篇 |
1990年 | 5篇 |
1989年 | 16篇 |
1988年 | 7篇 |
1987年 | 6篇 |
1986年 | 8篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 4篇 |
1977年 | 3篇 |
1971年 | 1篇 |
排序方式: 共有761条查询结果,搜索用时 15 毫秒
101.
R Miccoli G Odello O Giampietro P Marchetti R Cristofani G Penno G Meucci R Navalesi 《Ophthalmic research》1987,19(1):52-56
Plasma lipid levels have been proposed as probable risk factors of diabetic retinopathy. To clarify this question, we evaluated the apolipoprotein levels in 68 type I diabetic patients (39 +/- SD 14 years; duration of diabetes 13 +/- SD 8.4 years). By the analysis of fluorescein angiography we have classified diabetic retinopathy as follows: absent retinopathy (AR, n = 23), minimal retinopathy (MR, n = 16), exudative retinopathy (ER, n = 15), proliferative retinopathy (PR, n = 14). For all patients we measured: total, LDL- and HDL-cholesterol (T-CH, LDL-CH, HDL-CH), apolipoproteins A and B (Apo A and B), fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1). The mean age of the patients with ER (47 +/- SD 14 years) was greater than those with MR (36 +/- SD 15 years) or AR (33 +/- SD 13 years) (p less than 0.05). Significant differences within groups were not found for relative body weight, daily insulin dose, FPG, HbA1% (analysis of variance, ANOVA). The groups differed between each other with regard to T-CH, LDL-CH and HDL-CH/LDL-CH ratio (T-cholesterol: AR 186 +/- SD 34, MR 191 +/- SD 32, ER 212 +/- SD 52, PR 215 +/- SD 41 mg/dl; LDL-cholesterol: AR 124 +/- SD 28, MR 122 +/- SD 18, ER 148 +/- SD 38, PR 145 +/- SD 33 mg/dl; HDL/LDL-cholesterol ratio: AR 0.38 +/- SD 0.1, MR 0.35 +/- SD 0.1, ER 0.30 +/- SD 0.1, PR 0.29 +/- SD 0.1). The total-CH levels increased and HDL-CH/LDL-CH ratio decreased along with the severity of the retinopathy.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
102.
103.
William D. Donovan P. W. Brill Patricia Winchester Philip F. Giampietro Jessica G. Davis Madeleine Harbison 《Skeletal radiology》1996,25(3):269-271
Congenital fusion of the fourth and fifth metacarpals is described in a male infant and his maternal grandfather. Primary
gonadal failure, which is present in the infant, has not been noted in previously reported cases. The pedigree in this family
is compatible with X-linked recessive or autosomal dominant inheritance with incomplete penetrance. 相似文献
104.
Neurological Sciences - Migraine with aura (MwA) sufferers, at times, need specific treatments. This is the case when the auras are frequent, prolonged and cause anxiety and distress. Abnormal... 相似文献
105.
106.
107.
Caraceni T. Nordera N. Lamperti E. Lorizio A. 《The Italian Journal of Neurological Sciences》1989,10(4):407-414
The most important current problem in the treatment of Parkinson disease in the so-called L-dopa long-term-treatment syndrome.
We present here the results of our experience with Madopar HBS in the treatment of two groups of patients suffering from L-dopa
long-term treatment syndrome. In the first study we replaced the standard Madopar with Madopar HBS. In the second study, after
identifying the most disabling “off” periods, we added Madopar HBS to the previous treatment in such a way as to control these
“off” phases.
Our study suggests that Madopar HBS is useful in reducing typical fluctuation phenomena in the majority of patients.
Sommario Attualmente il problema più importante nel trattamento del morbo di Parkinson è costituito dalla cosiddetta “sindrome da trattamento cronico con L-dopa”. Presentiamo qui di seguito i risultati della nostra esperienza con Madopar HBS nel trattamento di 2 gruppi di pazienti affetti da tale sindrome. Nella prima parte dello studio abbiamo sostituito del tutto il Madopar standard con Madopar HBS, nella seconda parte, dopo aver identificato il periodo “off” maggiormente invalidante, abbiamo aggiunto Madopar HBS al trattamento precedente in modo che fosse efficace sulla fase off così identificata. Il nostro lavoro suggerisce che il Madopar HBS è utile nel ridurre le fluttuazioni motorie nella maggioranza dei pazienti parkinsoniani.相似文献
108.
109.
The main aim of the study was to identify the critical periods of susceptibility for itraconazole-mediated teratogenesis in the mouse. Pregnant ICR (CD-1) mice received a single oral administration of itraconazole at 50 mg/kg b.w., 150 mg/kg b.w. or 250 mg/kg b.w. on gestation day 8, 9, 10, 11 or 12. Control animals were administered with vehicle on gestation days 8-12. The gestational outcome was evaluated near term, on gestation day 18. Treatment-related morphological findings, as they can be evaluated by external, visceral and skeletal examination, mainly included cleft palate, limb defects and axial skeletal malformations. Cleft palate and limb defects resulted after single exposures between gestation days 9 and 11, with a tendency toward maximal response on gestation day 10. Significant incidences of axial skeletal defects were seen exclusively on gestation days 8 and 9. Exposure on gestation day 12 did not yield significant teratogenic responses. Cleft palate was the most sensitive teratogenic response, being the only developmental lesion associated to exposure to itraconazole at 150 mg/kg b.w. 相似文献
110.